DE2525633C3 - - Google Patents

Info

Publication number
DE2525633C3
DE2525633C3 DE2525633A DE2525633A DE2525633C3 DE 2525633 C3 DE2525633 C3 DE 2525633C3 DE 2525633 A DE2525633 A DE 2525633A DE 2525633 A DE2525633 A DE 2525633A DE 2525633 C3 DE2525633 C3 DE 2525633C3
Authority
DE
Germany
Prior art keywords
desmethoxydaunomycinone
daunosaminyl
adriamycin
anomers
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2525633A
Other languages
German (de)
English (en)
Other versions
DE2525633A1 (de
DE2525633B2 (US08197722-20120612-C00093.png
Inventor
Federico Nerviano Mailand Arcamone
Luigi Bernardi
Aurelio Di Dr. Mailand Marco
Bianca Patelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of DE2525633A1 publication Critical patent/DE2525633A1/de
Publication of DE2525633B2 publication Critical patent/DE2525633B2/de
Application granted granted Critical
Publication of DE2525633C3 publication Critical patent/DE2525633C3/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19752525633 1974-06-12 1975-06-09 Daunomycinanaloga Granted DE2525633A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2608374A GB1467383A (en) 1974-06-12 1974-06-12 Daunomycin analogues

Publications (3)

Publication Number Publication Date
DE2525633A1 DE2525633A1 (de) 1976-01-02
DE2525633B2 DE2525633B2 (US08197722-20120612-C00093.png) 1979-03-01
DE2525633C3 true DE2525633C3 (US08197722-20120612-C00093.png) 1979-10-18

Family

ID=10238087

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19752525633 Granted DE2525633A1 (de) 1974-06-12 1975-06-09 Daunomycinanaloga
DE1993175027 Active DE19375027I2 (de) 1974-06-12 1975-06-09 Alpha-Anomere von 4-Desmethoxy-daunomycin Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1993175027 Active DE19375027I2 (de) 1974-06-12 1975-06-09 Alpha-Anomere von 4-Desmethoxy-daunomycin Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (17)

Country Link
US (1) US4046878A (US08197722-20120612-C00093.png)
JP (1) JPS5840557B2 (US08197722-20120612-C00093.png)
AT (1) AT337363B (US08197722-20120612-C00093.png)
BE (1) BE830090A (US08197722-20120612-C00093.png)
BG (1) BG61059B2 (US08197722-20120612-C00093.png)
CH (1) CH611317A5 (US08197722-20120612-C00093.png)
DE (2) DE2525633A1 (US08197722-20120612-C00093.png)
DK (1) DK147304C (US08197722-20120612-C00093.png)
ES (1) ES438431A1 (US08197722-20120612-C00093.png)
FR (1) FR2274629A1 (US08197722-20120612-C00093.png)
GB (1) GB1467383A (US08197722-20120612-C00093.png)
HK (1) HK982A (US08197722-20120612-C00093.png)
MY (1) MY103666A (US08197722-20120612-C00093.png)
NL (1) NL173272C (US08197722-20120612-C00093.png)
SE (1) SE423633B (US08197722-20120612-C00093.png)
SU (1) SU645588A3 (US08197722-20120612-C00093.png)
ZA (1) ZA753722B (US08197722-20120612-C00093.png)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1509875A (en) * 1976-06-14 1978-05-04 Farmaceutici Italia Optically active anthracyclinones and anthracycline glycosides
US4161480A (en) * 1978-06-05 1979-07-17 G. D. Searle & Co. Intermediates for the synthesis of 4-demethoxydaunorubicin
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
IL55431A (en) * 1978-08-24 1982-07-30 Yeda Res & Dev Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them
NL8001417A (nl) * 1979-03-17 1980-09-19 Erba Farmitalia Antitumorglycosiden.
JPS5673039A (en) * 1979-08-20 1981-06-17 Hoffmann La Roche Naphthacene derivative
EP0024727B1 (en) * 1979-09-01 1982-05-26 FARMITALIA CARLO ERBA S.p.A. Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them
DE3100968A1 (de) * 1980-01-16 1982-01-14 Farmitalia Carlo Erba S.p.A., 20159 Milano Anthracyclinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4348388A (en) * 1980-04-02 1982-09-07 G.D. Searle & Co. 11-Amino-11-deoxydaunorubicin and analogs
ZA814722B (en) * 1980-07-18 1982-07-28 Hoffmann La Roche Novel anthracycline glycosides
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
GB8317037D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia 6-deoxyanthracyclines
US5138042A (en) * 1981-05-28 1992-08-11 Farmitalia Carlo Erba S.P.A. 6-deoxyanthracyclines
US4563444A (en) * 1982-05-26 1986-01-07 Farmitalia Carlo Erba S.P.A. Anthracycline glycosides, use and compositions containing same
US4604381A (en) * 1982-07-16 1986-08-05 Farmitalia Carlo Erba S.P.A. 4-demethoxy-13-dihydrodaunorubicin and use thereof
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4564674A (en) * 1983-10-31 1986-01-14 Sagami Chemical Research Center Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process
US4496485A (en) * 1983-11-25 1985-01-29 G. D. Searle & Co. Asymmetric 7-O-(substituted acetyl)-4-demethoxydaunomycinones
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
US4697005A (en) * 1985-03-20 1987-09-29 Ohio State University Research Foundation 1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
NZ224252A (en) * 1987-04-21 1991-09-25 Erba Carlo Spa An anthracycline glycoside and its preparation
JPS63191263U (US08197722-20120612-C00093.png) * 1987-05-29 1988-12-09
GB2212154B (en) * 1987-11-10 1991-03-27 Erba Carlo Spa New 4-demethoxy anthracycline derivatives
GB8803301D0 (en) * 1988-02-12 1988-03-09 Erba Carlo Spa Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
GB8808475D0 (en) * 1988-04-11 1988-05-11 Erba Carlo Spa Process for preparing 4-demethoxydauno-mycinone
GB8818167D0 (en) * 1988-07-29 1988-09-01 Erba Carlo Spa Novel 4-substituted anthracyclinones & process for their preparation
WO1993018050A1 (en) * 1992-03-02 1993-09-16 Pfizer Inc. Sugar derivatives of macrolides
US8252520B2 (en) * 2002-10-11 2012-08-28 Taivex Therapeutics Corporation Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
NZ593648A (en) * 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
CL2009002206A1 (es) * 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
EP2376514A2 (en) * 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
BR112012012160B1 (pt) 2009-11-13 2022-04-26 Amgen, Inc. Material e métodos para tratar ou prevenir doenças associadas ao her-3
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
CA2815154A1 (en) 2010-08-06 2012-02-09 U3 Pharma Gmbh Use of her3 binding agents in prostate treatment
DE102011113652A1 (de) 2011-09-19 2013-03-21 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Idarubicinhydrochlorid
EP4176871A1 (en) 2011-10-03 2023-05-10 Canqura Oncology Ab Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
WO2014163558A1 (en) 2013-04-01 2014-10-09 Moreinx Ab Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
EP3669890A1 (en) 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427300A (en) * 1965-11-12 1969-02-11 Merck & Co Inc Anti-inflammatory steroid 2'-acetamido-2'-deoxy-glucoside compounds
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
US3686163A (en) * 1968-05-14 1972-08-22 Farmaceutici Italia Dihydrodaunomycin antibiotic and derivatives thereof

Also Published As

Publication number Publication date
FR2274629A1 (fr) 1976-01-09
DK147304B (da) 1984-06-12
CH611317A5 (US08197722-20120612-C00093.png) 1979-05-31
JPS5840557B2 (ja) 1983-09-06
BE830090A (fr) 1975-12-11
GB1467383A (en) 1977-03-16
NL7506745A (nl) 1975-12-16
ES438431A1 (es) 1977-02-01
NL173272B (nl) 1983-08-01
SE7506589L (sv) 1975-12-15
JPS518260A (US08197722-20120612-C00093.png) 1976-01-23
SE423633B (sv) 1982-05-17
SU645588A3 (ru) 1979-01-30
MY103666A (en) 1993-08-28
US4046878A (en) 1977-09-06
DE2525633A1 (de) 1976-01-02
DE19375027I2 (de) 2002-06-13
DK256875A (da) 1975-12-13
AT337363B (de) 1977-06-27
AU8197975A (en) 1976-12-16
ZA753722B (en) 1976-09-29
DE2525633B2 (US08197722-20120612-C00093.png) 1979-03-01
HK982A (en) 1982-01-22
DK147304C (da) 1984-12-17
ATA437375A (de) 1976-10-15
BG61059B2 (bg) 1996-09-30
NL173272C (nl) 1984-01-02
FR2274629B1 (US08197722-20120612-C00093.png) 1980-01-11

Similar Documents

Publication Publication Date Title
DE2525633C3 (US08197722-20120612-C00093.png)
DE2510866C3 (de) 4'-epi-Adriamycin a - und ß -Anomer, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2819217A1 (de) Neue antitumoranthracycline
DE2652391C3 (de) Daunosaminylanthracyclinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3214559A1 (de) 4'-jododerivate von anthracyclinglykosiden und arzneimittel, welche diese enthalten
DE2627146B2 (de) Adriamycinester, Verfahren zu deren Herstellung und pharmazeutische Mittel enthaltend diese Adriamycinester
CH621799A5 (US08197722-20120612-C00093.png)
DE2804099A1 (de) Carminomycinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE2735455C3 (de) Daunomycinanaloga, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2819216A1 (de) Neue anthracyclinanaloga
AT392793B (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
DE2557537A1 (de) Daunomycinderivate und verfahren zu deren herstellung
DE2510926C3 (de) 4'-epi-Daunomycuie, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CH627478A5 (de) Verfahren zur herstellung von doxorubicinthioestern.
DE2063406C3 (de) Acylderivate des Proscillaridin A, Verfahren zu deren Herstellung und diese enthaltende Präparate
DE2435617C3 (de) L-Asparaginsäuresalz des cyklischen Erythromycin A-carbonats sowie ein Verfahren zur Herstellung desselben und pharmazeutische Mittel mit einem Gehalt dieser Verbindung
DE3123958C2 (de) Polymerverbindung MF-300 aus Ribostamycin und Crotonoylchlorid
AT371440B (de) Verfahren zur herstellung von neuen n-substituierten moranolinderivaten und ihrer saeureadditionssalze
DE2135191C3 (de) 3',4'-Didesoxykanamycin B, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE3121542C2 (de) 4-Desmethoxy-4'-desoxydoxorubicin-hydrochlorid und diese Verbindung enthaltende pharmazeutische Zubereitungen
AT341096B (de) Verfahren zur herstellung des neuen 4'-epi -6'- hydroxyadriamycins
DE3306505C2 (de) 4-Desmethoxy-13-dihydro-daunorubicin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE936268C (de) Verfahren zur Herstellung von neuen N-Methyl-trimethyl-colchicinsaeureamiden und ihren Salzen
AT381098B (de) Verfahren zur herstellung von anthracyclinglykosiden
DE1935563A1 (de) 1-betaD-Arabinofuranosylcytosin-5'-(1-adamantancarboxylat) und dessen Saeureadditionssalze sowie Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8327 Change in the person/name/address of the patent owner

Owner name: FARMITALIA CARLO ERBA S.R.L., MAILAND/MILANO, IT

8328 Change in the person/name/address of the agent

Free format text: DANNENBERG, G., DIPL.-ING., 6000 FRANKFURT WEINHOLD, P., DIPL.-CHEM. DR., 8000 MUENCHEN GUDEL, D., DR.PHIL. SCHUBERT, S., DIPL.-ING., 6000 FRANKFURT BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

V448 Application of spc

Free format text: PRODUCT NAME: IDARUBICIN; REGISTRATION NO/DATE: 19345.00.00, 19345.01.00; 19910411

Spc suppl protection certif: 193 75 027

Filing date: 19930524

V464 Spc expired

Free format text: PRODUCT NAME: IDARUBICIN; REGISTRATION NO/DATE: 19345.00.00, 19345.01.00; 19910411

Spc suppl protection certif: 193 75 027

Filing date: 19930524

V457 Spc granted

Free format text: PRODUCT NAME: IDARUBICIN; REGISTRATION NO/DATE: 19345.00.00, 19345.01.00; 19910411

Spc suppl protection certif: 193 75 027

Filing date: 19930524